CC-220
Showing 26 - 50 of 1,304
Newly Diagnosed Multiple Myeloma Trial in Spain (Bortezomib, Isatuximab, Iberdomide)
Not yet recruiting
- Newly Diagnosed Multiple Myeloma
- Bortezomib
- +4 more
-
Alcalá de Henares, Madrid, Spain
- +67 more
Sep 23, 2022
Acromioclavicular Joint Dislocation Trial in Chon Buri (K-wire)
Recruiting
- Acromioclavicular Joint Dislocation
- K-wire
-
Chon Buri, ThailandQueen Savang Vadhana Memorial Hospital
May 2, 2023
Cervical Cancer Trial (Game Changers for Cervical Cancer Prevention)
Not yet recruiting
- Cervical Cancer
- Game Changers for Cervical Cancer Prevention
- (no location specified)
Aug 17, 2023
NSCLC Trial in Worldwide (nab-paclitaxel IV, CC-486, Duravalumab)
Active, not recruiting
- Carcinoma, Non-Small-Cell Lung
- nab-paclitaxel IV
- +2 more
-
San Francisco, California
- +33 more
Jan 24, 2022
Lymphoma, Large B-Cell, Diffuse Trial in Worldwide (CC-122, CC-223, Rituximab)
Active, not recruiting
- Lymphoma, Large B-Cell, Diffuse
- CC-122
- +3 more
-
Santa Barbara, California
- +22 more
Jan 25, 2023
Same Morning vs Previous Evening Dosing Regimen for Assessment
Completed
- Bowel Preparation
-
Beijing, Beijing, China
- +1 more
Aug 14, 2023
Colorectal Cancer Trial (Administration of CC-3)
Not yet recruiting
- Colorectal Cancer
- Administration of CC-3
- (no location specified)
Aug 11, 2023
Epilepsy Trial in Toulouse (DIXI Medical Microdeep® Micro- Macro Depth electrodes, Standard electrodes)
Not yet recruiting
- Epilepsy
- DIXI Medical Microdeep® Micro- Macro Depth electrodes
- Standard electrodes
-
Toulouse, FranceUniversity Hospital of Toulouse
Oct 30, 2023
Advanced Solid Tumors Trial in Madrid ([14C]CC-90010, CC-90010)
Not yet recruiting
- Advanced Solid Tumors
-
Madrid, M, Spain
- +1 more
Dec 23, 2022
Application Site Discomfort Trial in Adana (water spray application)
Recruiting
- Application Site Discomfort
- water spray application
-
Adana, TurkeyAdana city training and research hospital
Nov 1, 2023
Insulin-Dependent Diabetes 1 Trial in Kayseri (High GI calculated by CC (CHGI), Low GI calculated by CC (CLGI), High GI
Completed
- Insulin-Dependent Diabetes Mellitus 1
- High GI calculated by CC (CHGI)
- +3 more
-
Kayseri, TurkeyErciyes University Faculty of Health Sciences
Feb 6, 2021
Risk Behaviors in Adolescents With Chronic Diseases
Recruiting
- Chronic Disease
- Somatic Disorders
- Questionnaire risk behaviors in adolescents with chronic diseases
-
Paris, FranceRobert Debre Hospital
Mar 20, 2023
Prostate Cancer Recurrent Trial in Tuebingen (CC-1 Infusion)
Recruiting
- Prostate Cancer Recurrent
- CC-1 Infusion
-
Tuebingen, GermanyUniversity Hospital Tuebingen
Jan 10, 2023
Follicular Lymphoma, Tumor Trial in Houston (Obinutuzumab, CC-99282)
Not yet recruiting
- Follicular Lymphoma
- Tumor
-
Houston, TexasM D Anderson Cancer Center
Oct 30, 2023
Chronic Constipation Trial in Lanzhou, Shenzhen, Xi'an (taVNS, Laxative Agent)
Recruiting
- Chronic Constipation
- taVNS
- Laxative Agent
-
Lanzhou, Gansu, China
- +4 more
Feb 9, 2023
Cancer Risk in Carriers of the Gene for Xeroderma Pigmentosum
Recruiting
- Xeroderma Pigmentosum
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Smoking Trial in Kajetany (CHTP 1.0, Conventional Cigarette (CC))
Completed
- Smoking
- CHTP 1.0
- Conventional Cigarette (CC)
-
Kajetany, PolandBioVirtus Research Site Sp. z o.o.
Jan 26, 2023
Healthy Volunteers Trial (CC-92480, Rifampin, Itraconazole)
Recruiting
- Healthy Volunteers
- CC-92480
- +4 more
-
Dallas, TexasCovance Clinical Research Unit - Dallas
Oct 25, 2022